A Dose Ranging Placebo-controlled Double-blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of 610 in Participants With Severe Eosinophilic Asthma

NCT05584306 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: 610 30mg group
DRUG: 610 100mg group
DRUG: 610 300mg group
OTHER: Placebo 30mg group
OTHER: Placebo 100mg group
OTHER: Placebo 300mg group

Sponsor

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.